Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRT PTPRE PTPRN2	6.55e-05	17	94	3	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRT PTPRE PTPRN2	6.55e-05	17	94	3	GO:0019198
GeneOntologyMolecularFunction	HLA-A specific inhibitory MHC class I receptor activity	LILRA1 LILRB2	2.17e-04	5	94	2	GO:0030107
GeneOntologyMolecularFunction	HLA-B specific inhibitory MHC class I receptor activity	LILRA1 LILRB2	3.25e-04	6	94	2	GO:0030109
GeneOntologyMolecularFunction	MHC class Ib protein complex binding	LILRA1 LILRB2	4.53e-04	7	94	2	GO:0023025
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	MRC1 TNFRSF25 LILRA1 PRLHR OR5M9 OPN4 LILRB2 GPR152 ADGRA2 PTPRT GPR160 UNC5A IGF2R PTPRE PTPRN2 TACR2	5.43e-04	1353	94	16	GO:0004888
GeneOntologyMolecularFunction	IgM binding	LILRA1 LILRB2	1.17e-03	11	94	2	GO:0001791
GeneOntologyMolecularFunction	amyloid-beta binding	HSPG2 LILRA1 LILRB2 NLGN1	1.38e-03	102	94	4	GO:0001540
GeneOntologyMolecularFunction	gamma-catenin binding	DSC3 PTPRT	1.40e-03	12	94	2	GO:0045295
GeneOntologyMolecularFunction	complement component C3b binding	CFHR4 CFHR3	1.40e-03	12	94	2	GO:0001851
GeneOntologyMolecularFunction	inhibitory MHC class I receptor activity	LILRA1 LILRB2	1.40e-03	12	94	2	GO:0032396
GeneOntologyBiologicalProcess	postsynaptic density protein 95 clustering	RELN NLGN1 SLC30A1 NLGN2	1.48e-07	11	97	4	GO:0097119
GeneOntologyBiologicalProcess	excitatory synapse assembly	RELN NLGN1 NLGN2 VSTM5 SEMA4A	2.44e-06	46	97	5	GO:1904861
GeneOntologyBiologicalProcess	postsynaptic density organization	RELN LILRB2 NLGN1 SLC30A1 NLGN2	7.80e-06	58	97	5	GO:0097106
GeneOntologyBiologicalProcess	regulation of synapse organization	RELN LILRB2 NLGN1 ZDHHC17 SLC30A1 SLITRK1 PTPRT NLGN2 VSTM5 SEMA4A	1.42e-05	387	97	10	GO:0050807
GeneOntologyBiologicalProcess	regulation of synapse structure or activity	RELN LILRB2 NLGN1 ZDHHC17 SLC30A1 SLITRK1 PTPRT NLGN2 VSTM5 SEMA4A	1.69e-05	395	97	10	GO:0050803
GeneOntologyBiologicalProcess	postsynaptic specialization organization	RELN LILRB2 NLGN1 SLC30A1 NLGN2	2.11e-05	71	97	5	GO:0099084
GeneOntologyBiologicalProcess	positive regulation of synapse assembly	NLGN1 SLITRK1 NLGN2 VSTM5 SEMA4A	5.34e-05	86	97	5	GO:0051965
GeneOntologyBiologicalProcess	positive regulation of excitatory synapse assembly	VSTM5 SEMA4A	6.55e-05	3	97	2	GO:1904891
GeneOntologyBiologicalProcess	postsynaptic membrane organization	RELN NLGN1 SLC30A1 NLGN2	1.40e-04	56	97	4	GO:0001941
GeneOntologyBiologicalProcess	neurotransmitter-gated ion channel clustering	RELN NLGN1 NLGN2	1.46e-04	22	97	3	GO:0072578
GeneOntologyBiologicalProcess	cell-cell adhesion	ZAN DSC2 DSC3 LILRB2 LAMA3 NLGN1 SLITRK1 PTPRT CFHR4 HMCN1 SMARCC1 SMARCD3 NLGN2 SIGLEC1 TNXB	1.47e-04	1077	97	15	GO:0098609
GeneOntologyBiologicalProcess	regulation of AMPA receptor activity	RELN NLGN1 NLGN2	2.15e-04	25	97	3	GO:2000311
GeneOntologyBiologicalProcess	regulation of excitatory synapse assembly	NLGN1 VSTM5 SEMA4A	2.42e-04	26	97	3	GO:1904889
GeneOntologyBiologicalProcess	regulation of postsynaptic density organization	LILRB2 NLGN1 SLC30A1	2.72e-04	27	97	3	GO:1905874
GeneOntologyBiologicalProcess	NMDA glutamate receptor clustering	RELN NLGN1	3.24e-04	6	97	2	GO:0097114
GeneOntologyBiologicalProcess	positive regulation of dendritic spine development	RELN NLGN1 SLC30A1 NLGN2	3.32e-04	70	97	4	GO:0060999
GeneOntologyCellularComponent	nuclear inner membrane	DPY19L2 SUN1 PLPP6 TMX4 TM7SF2	9.70e-06	59	101	5	GO:0005637
Domain	IG	HSPG2 LILRA1 LILRB2 ADGRA2 PTGFRN PTPRT UNC5A HMCN1 KIR2DL5A SIGLEC1 VSTM5	1.06e-05	421	96	11	SM00409
Domain	Ig_sub	HSPG2 LILRA1 LILRB2 ADGRA2 PTGFRN PTPRT UNC5A HMCN1 KIR2DL5A SIGLEC1 VSTM5	1.06e-05	421	96	11	IPR003599
Domain	Ig-like_dom	HSPG2 LILRA1 LILRB2 ADGRA2 PTGFRN PTPRT UNC5A HMCN1 KIR2DL5A SIGLEC1 VSTM5	5.42e-05	503	96	11	IPR007110
Domain	Ig-like_fold	HSPG2 LILRA1 LILRB2 ADGRA2 PTGFRN PTPRT UNC5A HMCN1 KIR2DL5A SIGLEC1 VSTM5 SEMA4A TNXB	6.46e-05	706	96	13	IPR013783
Domain	EGF	HSPG2 RELN ZAN LAMA3 HMCN1 ATRNL1 TNXB	2.10e-04	235	96	7	SM00181
Domain	IG_LIKE	HSPG2 LILRA1 LILRB2 ADGRA2 PTGFRN PTPRT UNC5A HMCN1 KIR2DL5A SIGLEC1	2.15e-04	491	96	10	PS50835
Domain	3-oxo-5_a-steroid_4-DH_C	TECR TECRL	2.59e-04	5	96	2	IPR001104
Domain	Nlgn	NLGN1 NLGN2	2.59e-04	5	96	2	IPR000460
Domain	Steroid_dh	TECR TECRL	2.59e-04	5	96	2	PF02544
Domain	S5A_REDUCTASE	TECR TECRL	2.59e-04	5	96	2	PS50244
Domain	EGF-like_dom	HSPG2 RELN ZAN LAMA3 HMCN1 ATRNL1 TNXB	2.99e-04	249	96	7	IPR000742
Domain	EGF_1	HSPG2 RELN ZAN LAMA3 HMCN1 ATRNL1 TNXB	3.46e-04	255	96	7	PS00022
Domain	EGF-like_CS	HSPG2 RELN ZAN LAMA3 HMCN1 ATRNL1 TNXB	3.97e-04	261	96	7	IPR013032
Domain	EGF_2	HSPG2 RELN ZAN LAMA3 HMCN1 ATRNL1 TNXB	4.35e-04	265	96	7	PS01186
Domain	ig	HSPG2 LILRA1 PTGFRN HMCN1 KIR2DL5A SIGLEC1	4.45e-04	190	96	6	PF00047
Domain	Immunoglobulin	HSPG2 LILRA1 PTGFRN HMCN1 KIR2DL5A SIGLEC1	4.45e-04	190	96	6	IPR013151
Domain	EGF_LAM_2	HSPG2 LAMA3 ATRNL1	4.83e-04	30	96	3	PS50027
Domain	EGF_LAM_1	HSPG2 LAMA3 ATRNL1	4.83e-04	30	96	3	PS01248
Domain	Desmosomal_cadherin	DSC2 DSC3	5.40e-04	7	96	2	IPR009122
Domain	Cadherin_pro	DSC2 DSC3	5.40e-04	7	96	2	PF08758
Domain	-	HSPG2 LILRA1 ADGRA2 PTGFRN PTPRT UNC5A HMCN1 KIR2DL5A SIGLEC1 VSTM5 TNXB	5.92e-04	663	96	11	2.60.40.10
Domain	Cadherin_pro_dom	DSC2 DSC3	7.17e-04	8	96	2	IPR014868
Domain	LAMININ_IVA	HSPG2 LAMA3	7.17e-04	8	96	2	PS51115
Domain	Laminin_B	HSPG2 LAMA3	7.17e-04	8	96	2	PF00052
Domain	Cadherin_pro	DSC2 DSC3	7.17e-04	8	96	2	SM01055
Domain	LamB	HSPG2 LAMA3	7.17e-04	8	96	2	SM00281
Domain	Laminin_IV	HSPG2 LAMA3	7.17e-04	8	96	2	IPR000034
Domain	EGF_Lam	HSPG2 LAMA3 ATRNL1	7.64e-04	35	96	3	SM00180
Domain	PTPc	PTPRT PTPRE PTPRN2	8.31e-04	36	96	3	SM00194
Domain	ConA-like_dom	HSPG2 ZAN LAMA3 PTPRT SEL1L3 PAPPA	9.36e-04	219	96	6	IPR013320
Domain	Laminin_EGF	HSPG2 LAMA3 ATRNL1	9.74e-04	38	96	3	IPR002049
Domain	TYR_PHOSPHATASE_PTP	PTPRT PTPRE PTPRN2	1.05e-03	39	96	3	PS50055
Domain	PTPase_domain	PTPRT PTPRE PTPRN2	1.22e-03	41	96	3	IPR000242
Domain	Y_phosphatase	PTPRT PTPRE PTPRN2	1.22e-03	41	96	3	PF00102
Domain	EGF_3	HSPG2 RELN ZAN HMCN1 ATRNL1 TNXB	1.34e-03	235	96	6	PS50026
Domain	-	MRC1 IGF2R	1.97e-03	13	96	2	2.10.10.10
Domain	Carboxylesterase_B_CS	NLGN1 NLGN2	1.97e-03	13	96	2	IPR019819
Domain	FN_type2_col-bd	MRC1 IGF2R	2.29e-03	14	96	2	IPR000562
Domain	FN2_2	MRC1 IGF2R	2.29e-03	14	96	2	PS51092
Domain	CARBOXYLESTERASE_B_2	NLGN1 NLGN2	2.29e-03	14	96	2	PS00941
Domain	fn2	MRC1 IGF2R	2.29e-03	14	96	2	PF00040
Domain	COesterase	NLGN1 NLGN2	2.29e-03	14	96	2	PF00135
Domain	FN2_1	MRC1 IGF2R	2.29e-03	14	96	2	PS00023
Domain	FN2	MRC1 IGF2R	2.29e-03	14	96	2	SM00059
Domain	CarbesteraseB	NLGN1 NLGN2	2.29e-03	14	96	2	IPR002018
Domain	Sushi	CFHR4 CFHR3 PAPPA	2.42e-03	52	96	3	PF00084
Domain	CCP	CFHR4 CFHR3 PAPPA	2.70e-03	54	96	3	SM00032
Domain	MAM_1	ZAN PTPRT	2.99e-03	16	96	2	PS00740
Domain	SUSHI	CFHR4 CFHR3 PAPPA	3.00e-03	56	96	3	PS50923
Domain	Sushi_SCR_CCP_dom	CFHR4 CFHR3 PAPPA	3.15e-03	57	96	3	IPR000436
Domain	MAM	ZAN PTPRT	3.38e-03	17	96	2	SM00137
Domain	PTPc_motif	PTPRT PTPRE PTPRN2	3.47e-03	59	96	3	SM00404
Domain	Tyr_Pase_cat	PTPRT PTPRE PTPRN2	3.47e-03	59	96	3	IPR003595
Domain	EGF_extracell	RELN ATRNL1 TNXB	3.64e-03	60	96	3	IPR013111
Domain	EGF_2	RELN ATRNL1 TNXB	3.64e-03	60	96	3	PF07974
Domain	Ig_V-set	HSPG2 PTGFRN HMCN1 SIGLEC1 VSTM5	3.65e-03	199	96	5	IPR013106
Domain	MAM	ZAN PTPRT	3.79e-03	18	96	2	PF00629
Domain	MAM_dom	ZAN PTPRT	3.79e-03	18	96	2	IPR000998
Domain	MAM_2	ZAN PTPRT	3.79e-03	18	96	2	PS50060
Domain	EGF	HSPG2 ZAN HMCN1 TNXB	4.07e-03	126	96	4	PF00008
Domain	Fibrinogen_CS	FCN1 TNXB	4.22e-03	19	96	2	IPR020837
Pubmed	Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn.	NLGN1 PTPRT NLGN2	4.87e-07	6	102	3	19816407
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	HSPG2 DSC3 TECR LAMA3 LGALS3BP IGF2R SEL1L3	5.78e-07	164	102	7	32409323
Pubmed	Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons.	NLGN1 NLGN2	8.52e-06	2	102	2	10892652
Pubmed	Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.	KIR2DL5B KIR2DL5A	8.52e-06	2	102	2	12185535
Pubmed	Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.	KIR2DL5B KIR2DL5A	8.52e-06	2	102	2	11086080
Pubmed	NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and strengthening.	NLGN1 NLGN2	8.52e-06	2	102	2	29278843
Pubmed	Hypersensitivity of excitation-contraction coupling in dystrophic cardiomyocytes.	OPN4 DMD	8.52e-06	2	102	2	19783774
Pubmed	Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.	KIR2DL5B KIR2DL5A	8.52e-06	2	102	2	17215859
Pubmed	Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4.	LILRB2 SEMA4A	8.52e-06	2	102	2	29467366
Pubmed	Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons.	NLGN1 NLGN2	8.52e-06	2	102	2	19889999
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	ADGRA2 PTGFRN PTPRT HMCN1 SIGLEC1 VSTM5	8.66e-06	162	102	6	25826454
Pubmed	The Genetic Basis of Baculum Size and Shape Variation in Mice.	CFHR4 CFHR3 PLCG1	1.33e-05	16	102	3	26935419
Pubmed	Assignment of the human genes for desmocollin 3 (DSC3) and desmocollin 4 (DSC4) to chromosome 18q12.	DSC2 DSC3	2.55e-05	3	102	2	7774948
Pubmed	Developmental expression and subcellular distribution of synaptotagmin 11 in rat hippocampus.	NLGN1 NLGN2	2.55e-05	3	102	2	22960622
Pubmed	Unique versus Redundant Functions of Neuroligin Genes in Shaping Excitatory and Inhibitory Synapse Properties.	NLGN1 NLGN2	2.55e-05	3	102	2	28607166
Pubmed	Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin.	CFHR4 CFHR3	2.55e-05	3	102	2	10622723
Pubmed	cDNA cloning and expression of a novel human desmocollin.	DSC2 DSC3	2.55e-05	3	102	2	7929347
Pubmed	Reelin is required for class-specific retinogeniculate targeting.	RELN OPN4	2.55e-05	3	102	2	21228166
Pubmed	Structure and function of desmosomal proteins and their role in development and disease.	DSC2 DSC3	2.55e-05	3	102	2	14523549
Pubmed	Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism.	NLGN1 NLGN2	2.55e-05	3	102	2	27217145
Pubmed	Desmocollin switching in colorectal cancer.	DSC2 DSC3	2.55e-05	3	102	2	17088906
Pubmed	Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.	IGF2R DMD	2.55e-05	3	102	2	18276788
Pubmed	Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits.	NLGN1 NLGN2	2.55e-05	3	102	2	29100073
Pubmed	Hemicentins assemble on diverse epithelia in the mouse.	DSC3 HMCN1	2.55e-05	3	102	2	17015624
Pubmed	Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.	JARID2 DMD	2.55e-05	3	102	2	24327761
Pubmed	Synaptic Adhesion Molecules Regulate the Integration of New Granule Neurons in the Postnatal Mouse Hippocampus and their Impact on Spatial Memory.	NLGN1 NLGN2	2.55e-05	3	102	2	27473321
Pubmed	Two factor H-related proteins from the mouse: expression analysis and functional characterization.	CFHR4 CFHR3	2.55e-05	3	102	2	17028856
Pubmed	Localization of complement factor H gene expression and protein distribution in the mouse outer retina.	CFHR4 CFHR3	2.55e-05	3	102	2	25684976
Pubmed	Promoter variants of KIR2DL5 add to diversity and may impact gene expression.	KIR2DL5B KIR2DL5A	2.55e-05	3	102	2	18461314
Pubmed	Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility.	CFHR4 CFHR3	2.55e-05	3	102	2	21637784
Pubmed	Neuroligins Sculpt Cerebellar Purkinje-Cell Circuits by Differential Control of Distinct Classes of Synapses.	NLGN1 NLGN2	2.55e-05	3	102	2	26291161
Pubmed	The influence of desmocollin 1-3 expression on prognosis after curative resection of colorectal liver metastases.	DSC2 DSC3	2.55e-05	3	102	2	23975055
Pubmed	Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses.	NLGN1 NLGN2	2.55e-05	3	102	2	17897391
Pubmed	Neuroligins determine synapse maturation and function.	NLGN1 NLGN2	2.55e-05	3	102	2	16982420
Pubmed	Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.	NLGN1 NLGN2	2.55e-05	3	102	2	17582332
Pubmed	Compositionally different desmosomes in the various compartments of the human hair follicle.	DSC2 DSC3	2.55e-05	3	102	2	9810708
Pubmed	Changing pattern of desmocollin 3 expression accompanies epidermal organisation during skin development.	DSC2 DSC3	2.55e-05	3	102	2	9389456
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	DSC2 DSC3 RHOT2 ADGRA2	4.64e-05	67	102	4	21875946
Pubmed	KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains.	KIR2DL5B KIR2DL5A	5.09e-05	4	102	2	10820258
Pubmed	Autism-related deficits via dysregulated eIF4E-dependent translational control.	NLGN1 NLGN2	5.09e-05	4	102	2	23172145
Pubmed	Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.	KIR2DL5B KIR2DL5A	5.09e-05	4	102	2	22652695
Pubmed	CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome.	CFHR4 CFHR3	5.09e-05	4	102	2	36793547
Pubmed	Plakoglobin as a regulator of desmocollin gene expression.	DSC2 DSC3	5.09e-05	4	102	2	23652796
Pubmed	LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.	LILRA1 LILRB2	5.09e-05	4	102	2	21559424
Pubmed	Neuroligin 2 regulates absence seizures and behavioral arrests through GABAergic transmission within the thalamocortical circuitry.	NLGN1 NLGN2	5.09e-05	4	102	2	32719346
Pubmed	Neuroligin 1, 2, and 3 Regulation at the Synapse: FMRP-Dependent Translation and Activity-Induced Proteolytic Cleavage.	NLGN1 NLGN2	5.09e-05	4	102	2	30056576
Pubmed	HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding.	LILRA1 LILRB2	5.09e-05	4	102	2	21270408
Pubmed	Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5.	KIR2DL5B KIR2DL5A	5.09e-05	4	102	2	18498296
Pubmed	Five SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin (SMARC) genes are dispersed in the human genome.	SMARCC1 SMARCD3	8.47e-05	5	102	2	9693044
Pubmed	Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells.	LILRA1 LILRB2	8.47e-05	5	102	2	18787130
Pubmed	Factor H-related proteins determine complement-activating surfaces.	CFHR4 CFHR3	8.47e-05	5	102	2	25979655
Pubmed	PIR-B Regulates CD4+ IL17a+ T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory Responses.	LILRA1 LILRB2	8.47e-05	5	102	2	34242819
Pubmed	Identification and sequence analysis of four complement factor H-related transcripts in mouse liver.	CFHR4 CFHR3	8.47e-05	5	102	2	1689298
Pubmed	The LILR family: modulators of innate and adaptive immune pathways in health and disease.	LILRA1 LILRB2	8.47e-05	5	102	2	15304001
Pubmed	Role of PIR-B in autoimmune glomerulonephritis.	LILRA1 LILRB2	8.47e-05	5	102	2	20976309
Pubmed	Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development.	NLGN1 NLGN2	8.47e-05	5	102	2	23358245
Pubmed	5-HT modulation of a medial septal circuit tunes social memory stability.	NLGN1 NLGN2	8.47e-05	5	102	2	34616037
Pubmed	Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury.	LILRA1 LILRB2	8.47e-05	5	102	2	20881122
Pubmed	PirB Overexpression Exacerbates Neuronal Apoptosis by Inhibiting TrkB and mTOR Phosphorylation After Oxygen and Glucose Deprivation Injury.	LILRA1 LILRB2	8.47e-05	5	102	2	27443384
Pubmed	The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling.	LILRA1 LILRB2	8.47e-05	5	102	2	15494528
Pubmed	Ectopically expressed PIR-B on T cells constitutively binds to MHC class I and attenuates T helper type 1 responses.	LILRA1 LILRB2	8.47e-05	5	102	2	19684158
Pubmed	PirB negatively regulates the inflammatory activation of astrocytes in a mouse model of sleep deprivation.	LILRA1 LILRB2	8.47e-05	5	102	2	37146940
Pubmed	PirB functions as an intrinsic suppressor in hippocampal neural stem cells.	LILRA1 LILRB2	8.47e-05	5	102	2	34120891
Pubmed	PirB regulates a structural substrate for cortical plasticity.	LILRA1 LILRB2	8.47e-05	5	102	2	24302763
Pubmed	Neuroligins Are Selectively Essential for NMDAR Signaling in Cerebellar Stellate Interneurons.	NLGN1 NLGN2	8.47e-05	5	102	2	27581450
Pubmed	Spatio-temporal expression of paired immunoglobulin-like receptor-B in the adult mouse brain after focal cerebral ischaemia.	LILRA1 LILRB2	8.47e-05	5	102	2	23927735
Pubmed	Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma.	DSC2 DSC3	8.47e-05	5	102	2	22438068
Pubmed	Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins.	NLGN1 NLGN2	8.47e-05	5	102	2	15620359
Pubmed	Enhancing motor learning by increasing the stability of newly formed dendritic spines in the motor cortex.	LILRA1 LILRB2	8.47e-05	5	102	2	34437845
Pubmed	Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4.	CFHR4 CFHR3	8.47e-05	5	102	2	20042240
Pubmed	Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus.	LILRA1 LILRB2	8.47e-05	5	102	2	37147336
Pubmed	The mammalian LINC complex component SUN1 regulates muscle regeneration by modulating drosha activity.	SUN1 DMD	8.47e-05	5	102	2	31686651
Pubmed	Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.	LILRA1 LILRB2	8.47e-05	5	102	2	33653799
Pubmed	Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury.	LILRA1 LILRB2	8.47e-05	5	102	2	21087927
Pubmed	Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis.	LILRA1 LILRB2	8.47e-05	5	102	2	20398663
Pubmed	Structure and flexibility of the extracellular region of the PirB receptor.	LILRA1 LILRB2	8.47e-05	5	102	2	30674550
Pubmed	Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence.	LILRA1 LILRB2	8.47e-05	5	102	2	23152562
Pubmed	Neuroligin-induced presynaptic differentiation through SLM2-mediated splicing modifications of neurexin in cerebellar cultures.	NLGN1 NLGN2	8.47e-05	5	102	2	28939043
Pubmed	Regulation of plasmacytoid dendritic cell responses by PIR-B.	LILRA1 LILRB2	8.47e-05	5	102	2	22948046
Pubmed	Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors.	LILRA1 LILRB2	8.47e-05	5	102	2	9054430
Pubmed	A radiation hybrid map of complement factor H and factor H-related genes.	CFHR4 CFHR3	8.47e-05	5	102	2	10380701
Pubmed	Synapse formation: if it looks like a duck and quacks like a duck ...	NLGN1 NLGN2	8.47e-05	5	102	2	10996085
Pubmed	Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B.	LILRA1 LILRB2	8.47e-05	5	102	2	10359805
Pubmed	Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus.	LILRA1 LILRB2	8.47e-05	5	102	2	27324131
Pubmed	Characterization of paired Ig-like receptors in rats.	LILRA1 LILRB2	8.47e-05	5	102	2	10586026
Pubmed	Chromosomal assignment of the human genes coding for the major proteins of the desmosome junction, desmoglein DGI (DSG), desmocollins DGII/III (DSC), desmoplakins DPI/II (DSP), and plakoglobin DPIII (JUP).	DSC2 DSC3	8.47e-05	5	102	2	1889810
Pubmed	Paired immunoglobulin-like receptor B regulates platelet activation.	LILRA1 LILRB2	8.47e-05	5	102	2	25075127
Pubmed	Genomic structure of PIR-B, the inhibitory member of the paired immunoglobulin-like receptor genes in mice.	LILRA1 LILRB2	8.47e-05	5	102	2	9550322
Pubmed	Expression of PirB protein in intact and injured optic nerve and retina of mice.	LILRA1 LILRB2	8.47e-05	5	102	2	22102155
Pubmed	Paired immunoglobulin-like receptors and their MHC class I recognition.	LILRA1 LILRB2	8.47e-05	5	102	2	16011512
Pubmed	Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages.	LILRA1 LILRB2	8.47e-05	5	102	2	23258232
Pubmed	Mast cell regulation via paired immunoglobulin-like receptor PIR-B.	LILRA1 LILRB2	8.47e-05	5	102	2	12403357
Pubmed	Nomenclature of the desmosomal cadherins.	DSC2 DSC3	8.47e-05	5	102	2	8486729
Pubmed	Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms.	NLGN1 NLGN2	8.47e-05	5	102	2	37865312
Pubmed	Autoimmune arthritis induces paired immunoglobulin-like receptor B expression on CD4+ T cells from SKG mice.	LILRA1 LILRB2	1.27e-04	6	102	2	28664612
Pubmed	The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?	NLGN1 NLGN2	1.27e-04	6	102	2	21838267
Pubmed	HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor.	LILRA1 LILRB2	1.27e-04	6	102	2	12207326
Pubmed	Cell-Autonomous Regulation of Dendritic Spine Density by PirB.	LILRA1 LILRB2	1.27e-04	6	102	2	27752542
Pubmed	The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate.	LILRA1 LILRB2	1.27e-04	6	102	2	9824165
Pubmed	CaSSiDI: novel single-cell "Cluster Similarity Scoring and Distinction Index" reveals critical functions for PirB and context-dependent Cebpb repression.	LILRA1 LILRB2	1.27e-04	6	102	2	38383888
Interaction	TAFA2 interactions	LAMA3 IGF2R ATRNL1 KIR2DL5A NLGN2	2.89e-06	47	96	5	int:TAFA2
Interaction	LILRA3 interactions	LILRA1 DSC2 LILRB2	1.68e-05	11	96	3	int:LILRA3
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRT PTPRE PTPRN2	7.03e-05	21	70	3	813
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	MRC1 LILRA1 LILRB2 PTGFRN IGF2R TSPAN7 KIR2DL5A SIGLEC1	1.37e-04	394	70	8	471
GeneFamily	Desmosomal cadherins	DSC2 DSC3	3.06e-04	7	70	2	1188
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFHR4 CFHR3 PAPPA	1.40e-03	57	70	3	1179
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DL5B KIR2DL5A	2.17e-03	18	70	2	620
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HSPG2 UNC5A HMCN1 SIGLEC1	3.52e-03	161	70	4	593
GeneFamily	Fibrinogen C domain containing	FCN1 TNXB	4.18e-03	25	70	2	554
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN HEPH UNC5A PTPRE TNXB DYNC1I1	7.33e-08	164	97	7	a784f47f67a5eda84d58ad7d9400e3978edbb487
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN HEPH UNC5A PTPRE TNXB DYNC1I1	7.33e-08	164	97	7	1a1795969673232191425dde84ab24ee6a98143f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN HEPH UNC5A PTPRE TNXB DYNC1I1	7.33e-08	164	97	7	8f074940afdbda88a4b697a7ddc687e09a4b818b
ToppCell	metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	HSPG2 RELN ADGRA2 HEPH UNC5A TSPAN7 DYNC1I1	1.10e-07	174	97	7	d551bc29afef071adf4c9bb80345352ec33441d8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN PRLHR UNC5A PTPRE RPGR TNXB	2.00e-07	190	97	7	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN PRLHR UNC5A PTPRE RPGR TNXB	2.00e-07	190	97	7	be9f36127028f52ca5fc1b32ba15a6c26aad69ac
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN PRLHR UNC5A PTPRE RPGR TNXB	2.00e-07	190	97	7	09a8855901c3c9332dbaab3e40166485b696d0f1
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	MRC1 HSPG2 RELN PTPRT ATRNL1 TSPAN7 DYNC1I1	2.47e-07	196	97	7	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-DC2\|lymph-node_spleen / Manually curated celltypes from each tissue	MRC1 LILRA1 DSC2 LILRB2 PTPRE FCN1 SEMA4A	2.47e-07	196	97	7	9666b5380e2b2a3c3b56a8c769817a1df8820ed6
ToppCell	metastatic_Lymph_Node-Endothelial_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	HSPG2 RELN ADGRA2 HEPH UNC5A TSPAN7	2.50e-06	177	97	6	71bf5d4bc67bda37a0499e5ec01af7dd5254041d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN ZAN HMCN1 DGKK DMD	3.13e-06	184	97	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN ZAN HMCN1 DGKK DMD	3.13e-06	184	97	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM RELN ZAN HMCN1 DGKK DMD	3.13e-06	184	97	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic\|GI_large-bowel / Manually curated celltypes from each tissue	MRC1 LILRA1 LILRB2 FCN1 CC2D2A SIGLEC1	3.54e-06	188	97	6	d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_large-bowel / Manually curated celltypes from each tissue	MRC1 LILRA1 LILRB2 FCN1 CC2D2A SIGLEC1	3.54e-06	188	97	6	0bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 HSPG2 RELN ADGRA2 UNC5A TNXB	3.54e-06	188	97	6	26915db8863f4115b46a81982e187322e21600fd
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 HSPG2 RELN ADGRA2 UNC5A TNXB	3.54e-06	188	97	6	3f76c0f912f8f023ea425be7f43593b3d7f967e3
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 HSPG2 RELN ADGRA2 UNC5A TNXB	3.54e-06	188	97	6	61ee7b152745164293d8a44ef91ee2393efbdca5
ToppCell	IPF-Myeloid-cMonocyte\|Myeloid / Disease state, Lineage and Cell class	LILRA1 LILRB2 JARID2 PTPRE FCN1 SMARCD3	3.65e-06	189	97	6	ad7bb3a7de8e48c145e4382f90d30bb2159c2b76
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RELN PTPRE HMCN1 RPGR TNXB DYNC1I1	3.76e-06	190	97	6	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MRC1 LILRA1 DSC2 LILRB2 PTPRE FCN1	4.37e-06	195	97	6	403d874198a7bde626b0d0b4efad8dbb34060761
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	LILRA1 LILRB2 JARID2 PTPRE FCN1 L3MBTL3	4.37e-06	195	97	6	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	Monocytes-IL1B+_Monocytes\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	DSC2 LILRB2 PTPRE FCN1 SIGLEC1 SEMA4A	4.50e-06	196	97	6	7bc0735d324ac5a1661434cda4116ddd58296730
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM1\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	LILRB2 PTPRE FCN1 SIGLEC1 SEMA4A TDRD6	4.50e-06	196	97	6	7c8aa5853d7096628e35af665097c0299c329753
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM1-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LILRB2 PTPRE FCN1 SIGLEC1 SEMA4A TDRD6	4.50e-06	196	97	6	f60b220ed117bcc33e0f7bbf5b53d3b1422ebaca
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM1-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LILRB2 PTPRE FCN1 SIGLEC1 SEMA4A TDRD6	4.50e-06	196	97	6	bcd274db4955ea76ca26267a272c7d1929db24f4
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MRC1 LILRA1 DSC2 LILRB2 PTPRE FCN1	4.50e-06	196	97	6	f943519bff51c3094776fd45889dadf9062c8379
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LILRB2 PTPRE FCN1 SIGLEC1 SEMA4A TDRD6	4.50e-06	196	97	6	80b9139d91dda4de69830d2d443859e047ab5503
ToppCell	Mild_COVID-19-Myeloid-MoAM1\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	LILRB2 PTPRE FCN1 SIGLEC1 SEMA4A TDRD6	4.50e-06	196	97	6	ea3fbe81b4ecb6ccc8031f6d99da93c9f9f8c1aa
ToppCell	(6)_Macrophage\|World / shred on Cell_type and subtype	MRC1 LILRA1 DSC2 LILRB2 FCN1 SIGLEC1	4.63e-06	197	97	6	010b275d4da4a896175ad7fbaa96d1dc11a0b744
ToppCell	myeloid-Monocyte\|myeloid / Lineage, cell class and subclass	LILRA1 DSC2 LILRB2 IGF2R FCN1 SMARCD3	4.63e-06	197	97	6	6acf059cee6ba6bdeacc089b090d72336790972a
ToppCell	distal-2-Hematologic-Classical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRA1 LILRB2 JARID2 PTPRE FCN1 SMARCD3	4.63e-06	197	97	6	9a1c9221904ad1e46e64e3785516804e87128adc
ToppCell	BAL-Mild-Myeloid-MoAM\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LILRB2 PTPRE FCN1 SIGLEC1 SEMA4A TDRD6	4.63e-06	197	97	6	0f40dd3530eb8d02e79b32f942efe3b65b8f6ee6
ToppCell	BAL-Mild-Myeloid-MoAM\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	LILRB2 PTPRE FCN1 SIGLEC1 SEMA4A TDRD6	4.63e-06	197	97	6	a6aa5991d566c28440f7e24a30933e69669064f2
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MRC1 RELN UNC5A PTPRE RPGR DYNC1I1	4.77e-06	198	97	6	b3a020522e064bb61949d38e442f24026e339364
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MRC1 RELN UNC5A PTPRE RPGR DYNC1I1	4.77e-06	198	97	6	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Lymphatic\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	HSPG2 RELN UNC5A PTPRE RPGR TNXB	4.91e-06	199	97	6	88f33b8dcd837abfa1d12c28719e073a7da6e979
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSPG2 RELN UNC5A PTPRE RPGR TNXB	4.91e-06	199	97	6	64b19aff72e2a109cb5857cb248bd4712dd49b43
ToppCell	3'_v3-Lung-Myeloid_Monocytic\|Lung / Manually curated celltypes from each tissue	LILRA1 LILRB2 JARID2 PTPRE FCN1 SMARCD3	4.91e-06	199	97	6	3e14f9a62d6414add8d5f681be184b4625001838
ToppCell	3'_v3-Lung-Myeloid_Monocytic-Classical_monocytes\|Lung / Manually curated celltypes from each tissue	LILRA1 LILRB2 JARID2 PTPRE FCN1 SMARCD3	4.91e-06	199	97	6	bfd0d171ea6bb7abd5cdfeac22608cc190aaa2be
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 LILRA1 LILRB2 PTPRE FCN1 SIGLEC1	4.91e-06	199	97	6	41d240d44bd6cc301a7879cacee104c874b4ba2c
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSPG2 RELN UNC5A PTPRE RPGR TNXB	4.91e-06	199	97	6	2b9e1e069b36b3a61cc3e384f4523687b0e03905
ToppCell	Transverse-(6)_Macrophage\|Transverse / shred on region, Cell_type, and subtype	MRC1 LILRA1 LILRB2 PTPRE FCN1 SIGLEC1	5.05e-06	200	97	6	b28350de555fa756d2631f004f71d5ac69b1affe
ToppCell	mLN-Macrophage\|mLN / Region, Cell class and subclass	MRC1 LILRA1 DSC2 LILRB2 FCN1 SIGLEC1	5.05e-06	200	97	6	68d709afd226241e002dae6d6820bccd1cfd87a1
ToppCell	Caecum-Macrophage-Macrophage\|Caecum / Region, Cell class and subclass	MRC1 LILRA1 DSC2 LILRB2 FCN1 SIGLEC1	5.05e-06	200	97	6	99dcf07b17ecf90d596f3b8a12d5b7aae2a351d5
ToppCell	Transverse-Macrophage\|Transverse / Region, Cell class and subclass	MRC1 LILRA1 LILRB2 PTPRE FCN1 SIGLEC1	5.05e-06	200	97	6	1920605e5811938814d02b971069a4506868db5f
ToppCell	mLN-(6)_Macrophage\|mLN / shred on region, Cell_type, and subtype	MRC1 LILRA1 DSC2 LILRB2 FCN1 SIGLEC1	5.05e-06	200	97	6	6dcba82a7d322102bae205543086e84c7655b3e0
ToppCell	Caecum-(6)_Macrophage-(60)_Macrophage\|Caecum / shred on region, Cell_type, and subtype	MRC1 LILRA1 DSC2 LILRB2 FCN1 SIGLEC1	5.05e-06	200	97	6	67b6cdeb07ffc5c9af7a3e738dd31256cf391e98
ToppCell	Caecum-(6)_Macrophage\|Caecum / shred on region, Cell_type, and subtype	MRC1 LILRA1 DSC2 LILRB2 FCN1 SIGLEC1	5.05e-06	200	97	6	2ce3930645c3daf6be578f7881e57a58df61e75c
ToppCell	Caecum-Macrophage\|Caecum / Region, Cell class and subclass	MRC1 LILRA1 DSC2 LILRB2 FCN1 SIGLEC1	5.05e-06	200	97	6	d83209559187a4419df2508ecc5eb9f7d72fced3
ToppCell	distal-1-Hematologic-Classical_Monocyte\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRA1 LILRB2 JARID2 PTPRE FCN1 SMARCD3	5.05e-06	200	97	6	3e672dd51ed72e8109691e5ca2fa2801b0539958
ToppCell	(60)_Macrophage\|World / shred on Cell_type and subtype	MRC1 LILRA1 DSC2 LILRB2 FCN1 SIGLEC1	5.66e-06	204	97	6	06d0cb306f1ad0014d81f8228868938e48c2bcf3
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRC1 PRLHR LILRB2 PTGFRN SIGLEC1	9.71e-06	130	97	5	92913960e4367261ba08a405b61a421bc5e18169
ToppCell	Parenchymal-10x3prime_v2-Hematologic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KIAA0825 L3MBTL3 MCOLN2	2.16e-05	25	97	3	7b267cdcb6afcf603d566c4d5268eb44eacf47b6
ToppCell	Parenchymal-10x3prime_v2-Hematologic-Erythrocyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KIAA0825 L3MBTL3 MCOLN2	2.16e-05	25	97	3	096ca30d9277cfd9cb2501c40b085cc358cb628b
ToppCell	Parenchymal-10x3prime_v2-Hematologic-Erythrocyte-Erythrocyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KIAA0825 L3MBTL3 MCOLN2	2.16e-05	25	97	3	3d7b43ecf6ae64996d91765c50f614742e18bd25
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MRC1 RELN LILRB2 HEPH FCN1	2.20e-05	154	97	5	c6ecc46b99a783373729f7fae0b23216148ffb78
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAJC21 PTGFRN EML3 L3MBTL3 TNXB	2.64e-05	160	97	5	778faada072e3abfa76a9a06fd4885fb63de7902
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 PTGFRN PTPRT HEPH L3MBTL3	2.81e-05	162	97	5	b502d6af6868425b5c919740e011330c0d3cf3b8
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8\|TCGA-Thryoid / Sample_Type by Project: Shred V9	ST6GALNAC6 EML3 DMD CA5B L3MBTL3	3.34e-05	168	97	5	00646601548b0fee42ae16bfa5e93603bc7c5129
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B0\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TNFRSF25 AOC3 NLGN2 PLCG1 MCOLN2	3.44e-05	169	97	5	89b5452e0d8d058648a1d2659f1611fd6aebc6b6
ToppCell	390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|390C / Donor, Lineage, Cell class and subclass (all cells)	MRC1 CATSPERE DSC2 LILRB2 SIGLEC1	3.44e-05	169	97	5	2c851b2703c7b8b656026f996f5fc027e4a79b36
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	MRC1 MGAM LILRB2 TECRL SIGLEC1	3.53e-05	170	97	5	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN DPY19L2 ADGRA2 RPGR TNXB	3.84e-05	173	97	5	85083b9ce20351dd69aa2327ad087b848b4307ff
ToppCell	Basal_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	DSC2 RHOT2 HMCN1 KIAA0825 TDRD6	3.95e-05	174	97	5	a0060be3940043015dcc49a5157de5541aed24a1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN PGAP2 TAF5 TNXB	4.06e-05	175	97	5	9a96a946db731ba24c9be34bedebf1f4a1372b9e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN PGAP2 TAF5 TNXB	4.06e-05	175	97	5	54c1f080195ad8392a095e83b56a4b54073d4c0d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN PGAP2 TAF5 TNXB	4.06e-05	175	97	5	2b51406a2c2daa13ab4ed283ede038cd11d9e641
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|normal_Lymph_Node / Location, Cell class and cell subclass	LILRA1 CATSPERE LILRB2 SUN1 MCOLN2	4.17e-05	176	97	5	476794ef75ce5ab732d78cfeb4944e2f841e3e92
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	MRC1 RELN PTPRE TNXB DYNC1I1	4.17e-05	176	97	5	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	MRC1 RELN PTPRE TNXB DYNC1I1	4.17e-05	176	97	5	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	Monocytes-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	LILRA1 LILRB2 JARID2 PTPRE FCN1	4.17e-05	176	97	5	5b5f8655b0c6c56f98f70bce13e71f017d4b75a5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN TMPRSS6 UNC5A PTPRE	4.28e-05	177	97	5	c274fbdc141855ff4581d437d4997c64cc193278
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN ADGRA2 PTPRE TNXB	4.28e-05	177	97	5	227d4f423b00be2e0c5797e2c5275d342e69a0f4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN TMPRSS6 UNC5A PTPRE	4.28e-05	177	97	5	f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN ADGRA2 PTPRE TNXB	4.28e-05	177	97	5	66ffa279147961080c104242a08b176e301d80e3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN TMPRSS6 UNC5A PTPRE	4.28e-05	177	97	5	c8a51e480b978dc0ded85583261f2c892e085be8
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN ADGRA2 PTPRE TNXB	4.28e-05	177	97	5	0cbf54608d2ba0a0500af142f2029fe5e118c3c2
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PTGFRN HMCN1 ATRNL1 TSPAN7	4.28e-05	177	97	5	8ef41ee5d63737b810ad7371b0437625e7e1badf
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 LILRA1 PTPRE FCN1 MCOLN2	4.40e-05	178	97	5	8184a2b9872f7ca12a9823535de485e841aeffb1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DDIT4L NLGN1 PTPRT SEL1L3 SEMA4A	4.40e-05	178	97	5	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MIOX LILRB2 FCN1 SEMA4A MCOLN2	4.52e-05	179	97	5	ce95b601bf17ae8167d382a105384b9e65e9407f
ToppCell	normal_Lymph_Node-Myeloid_cells-Pleural_Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	MRC1 LILRA1 LILRB2 FCN1 SIGLEC1	4.76e-05	181	97	5	921e917f83105896ad8918dc134b871708024021
ToppCell	Severe-Lymphoid-pDC\|Severe / Condition, Lineage, Cell class and cell subclass	ZAN ZDHHC17 SEL1L3 DMD MCOLN2	4.76e-05	181	97	5	2caecb7c5dcdad46fd02b4ffb73cb613ce835187
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PTGFRN HMCN1 ATRNL1 TSPAN7	4.76e-05	181	97	5	4df7972f88117108698efd06b124b232f8588981
ToppCell	Endothelial-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	RELN ADGRA2 KIAA0825 TSPAN7 TNXB	4.76e-05	181	97	5	4fe0215d08f03d4e24749d70fce01b7aa22906fd
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MIOX LILRB2 FCN1 SIGLEC1 MCOLN2	4.76e-05	181	97	5	090e89b506d945e123e647d08947e9649a65ce7c
ToppCell	Control-Myeloid\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRC1 LILRA1 PTPRE FCN1 SEMA4A	4.76e-05	181	97	5	25170e5285996cc80337d5f86a0255569861ae77
ToppCell	Severe-Lymphoid-pDC-\|Severe / Condition, Lineage, Cell class and cell subclass	ZAN ZDHHC17 SEL1L3 DMD MCOLN2	4.76e-05	181	97	5	277ce4c49121da0990a5933b19d2c6af9bbe253e
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PTGFRN HMCN1 ATRNL1 TSPAN7	4.76e-05	181	97	5	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRC1 LILRB2 PTGFRN SIGLEC1 SEMA4A	4.89e-05	182	97	5	9a68d3bd1cc9139de9e9e711c249d47ade826bb1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRC1 LILRB2 PTGFRN SIGLEC1 SEMA4A	4.89e-05	182	97	5	d57d18732aa6fb7b2d430601568f9ba525ac6e3c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN UNC5A PTPRE TNXB	4.89e-05	182	97	5	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN UNC5A PTPRE TNXB	4.89e-05	182	97	5	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 RELN UNC5A PTPRE TNXB	4.89e-05	182	97	5	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	wk_15-18-Hematologic-Myeloid-pre-pDC/DC5\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LILRA1 PTPRE SEL1L3 SEMA4A MCOLN2	4.89e-05	182	97	5	748401d2c84260a777001dd75b0182453185addc
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRC1 LILRB2 PTGFRN SIGLEC1 SEMA4A	4.89e-05	182	97	5	c3fb1460160744144aa31afc76c0a4d42ebdeb91
ToppCell	droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN TMPRSS6 GPR160 DMD CA5B	5.02e-05	183	97	5	ffb1bbbccb34d1a7e99872611f497450039d5019
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ATRNL1 PAPPA NLGN2 DMD TNXB	5.02e-05	183	97	5	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Macrophages\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MRC1 LILRA1 LILRB2 PTPRE FCN1	5.02e-05	183	97	5	92d5a61b57851090eba558f19e2a7010043eff81
Disease	Age related macular degeneration	CFHR4 CFHR3 HMCN1 RPGR	2.48e-06	30	94	4	C0242383
Disease	non-syndromic intellectual disability (implicated_via_orthology)	TECR TECRL	1.00e-05	2	94	2	DOID:0050889 (implicated_via_orthology)
Disease	disease	NLGN1 SLC14A2 DYNC1I1	3.99e-05	21	94	3	EFO_0000408
Disease	age related macular degeneration 1 (is_implicated_in)	CFHR3 HMCN1	6.00e-05	4	94	2	DOID:0110014 (is_implicated_in)
Disease	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement	CFHR4 CFHR3	6.00e-05	4	94	2	EFO_0803292
Disease	Macular Degeneration, Age-Related, 1	CFHR3 HMCN1	6.00e-05	4	94	2	C1864205
Disease	MACULAR DEGENERATION, AGE-RELATED, 1	CFHR3 HMCN1	6.00e-05	4	94	2	603075
Disease	Age related macular degeneration 1	CFHR3 HMCN1	6.00e-05	4	94	2	cv:C1864205
Disease	arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology)	DSC2 DSC3	9.98e-05	5	94	2	DOID:0050431 (implicated_via_orthology)
Disease	desmocollin-2 measurement	DSC2 DSC3	9.98e-05	5	94	2	EFO_0021936
Disease	galectin-3-binding protein measurement	LGALS3BP SIGLEC1	1.49e-04	6	94	2	EFO_0010241
Disease	Ventricular Dysfunction	IGF2R DMD	2.78e-04	8	94	2	C0242973
Disease	status epilepticus (biomarker_via_orthology)	RELN NLGN1 NLGN2 DMD	3.00e-04	100	94	4	DOID:1824 (biomarker_via_orthology)
Disease	Hemolytic-uremic syndrome	CFHR4 CFHR3	3.56e-04	9	94	2	cv:C0019061
Disease	Coffin-Siris syndrome (implicated_via_orthology)	SMARCC1 SMARCD3	3.56e-04	9	94	2	DOID:1925 (implicated_via_orthology)
Disease	Atypical hemolytic-uremic syndrome	CFHR4 CFHR3	3.56e-04	9	94	2	cv:C2931788
Disease	Muscle Weakness	CAMKMT DMD	4.44e-04	10	94	2	C0151786
Disease	hepcidin:transferrin saturation ratio	TMPRSS6 SLITRK1	1.03e-03	15	94	2	EFO_0007902
Disease	response to triptolide, cytotoxicity measurement	TECRL ADGRA2	1.17e-03	16	94	2	EFO_0006952, EFO_0007662
Disease	wheezing	NLGN1 SLITRK1 PTPRN2	1.19e-03	65	94	3	EFO_0009715
Disease	Age-related macular degeneration	CFHR3 HMCN1	1.49e-03	18	94	2	cv:C0242383
Disease	Parkinson's disease (implicated_via_orthology)	PRLHR RHOT2 PTPRN2 TSPAN7	1.62e-03	157	94	4	DOID:14330 (implicated_via_orthology)
Disease	carotid artery disease (is_marker_for)	HSPG2 PAPPA	1.66e-03	19	94	2	DOID:3407 (is_marker_for)
Disease	complement factor H-related protein 3 measurement	PTPRT CFHR4 CFHR3 DMD	2.12e-03	169	94	4	EFO_0600056
Disease	triacylglycerol 58:9 measurement	PTPRT TNXB	2.23e-03	22	94	2	EFO_0010443
Disease	mortality	PEDS1 PAPPA TACR2 DMD	2.31e-03	173	94	4	EFO_0004352
Disease	risk-taking behaviour	RELN NLGN1 PTPRN2 ATRNL1 CC2D2A CAMKMT MTX1 TNXB	3.07e-03	764	94	8	EFO_0008579

Protein segments in the cluster

Peptide	Gene	Start	Entry
SYQVTSECWSPFHYQ	nan	131	A8MT66
SCYHPNGNVWVYINI	ERICH6	491	Q7L0X2
SYDPATCLHVWNNGY	CA5B	86	Q9Y2D0
VWGPENYKHCFSYAI	CATSPERE	826	Q5SY80
AGRWEPGDYSHCLYT	ADGRA2	406	Q96PE1
CDETFNYWEPTHYLI	ALG9	81	Q9H6U8
CGYHPESLLSDFDYW	DDIT4L	21	Q96D03
PYYINHETQTTCWDH	DMD	3071	P11532
YTYSEWHSFTQPRLG	DSC2	821	Q02487
GVDCPYLATYVDWHF	AOC3	401	Q16853
PLYQFHCWYEVTCVQ	NWD2	1091	Q9ULI1
LRCQVSGSPPHYFYW	HSPG2	1696	P98160
CYHYWPDEGSNLYHI	PTPRN2	856	Q92932
YTCFGSLHDSPYEWS	KIR2DL5A	191	Q8N109
SYDYWCEASSPHIHP	L3MBTL3	411	Q96JM7
VAFAYWNHYLSCTSP	PGAP2	91	Q9UHJ9
NPFLVGMHCWYSSYS	DGKK	321	Q5KSL6
CYQYWPTEGSVTHGE	PTPRE	536	P23469
YSPWQYFAHSKVDCL	LAMA3	181	Q16787
LYWVSCISHFYPSLL	KIAA0825	771	Q8IV33
VYLPTIQSCWNYGFS	LGALS3BP	481	Q08380
VSHFPCYQWIEGYCT	ALOXE3	96	Q9BYJ1
SLQFLGQWGYHCYEP	ASB17	31	Q8WXJ9
SVPWCYYSKNHSYHV	MGAM	126	O43451
QPLHFLTWDTCYFHY	DYNC1I1	76	O14576
YTCFSSLHDSPYEWS	KIR2DL5B	191	Q8NHK3
PHETYFCITTGWLNY	PEDS1	221	A5PLL7
PSITWEHTGRYGCQY	LILRB2	86	Q8N423
HWPLGTAACRFYYFL	GPR152	96	Q8TDT2
EHCHSSGLPYWLYLT	NPIPB7	221	O75200
YAFYHHCQTDQVPAW	NLGN1	526	Q8N2Q7
GISQHAWYPCTISYP	PAPPA	1061	Q13219
FHLYPEVIIASWYCT	DPY19L2	191	Q6NUT2
TVVHPFYAYWQSFCT	DNAJC21	146	Q5F1R6
YLGNVQPYCGHDWTL	RELN	886	P78509
DGISIPYTWNHTVFY	HMCN1	5031	Q96RW7
QWEPFGYAVTRCHSY	PTPRT	406	O14522
CFQKHYYPSEWTVQL	PRSS41	96	Q7RTY9
WSLPCGVSHLLPYFY	TM7SF2	361	O76062
SRHCPFYVSIQSYWL	GPR160	171	Q9UJ42
AYVPEGLLTSCSWDY	OPN4	211	Q9UHM6
YFLSGWHTIYLPDCR	FCN1	126	O00602
TPSGSYWDYIHCTQN	CFHR3	61	Q02985
RYLIWNPCSGHFYGQ	CC2D2A	1406	Q9P2K1
YTYSEWHSFTQPRLG	DSC3	816	Q14574
YIISFPYGQCLEWQT	ATRNL1	921	Q5VV63
VTPSGSYWDYIHCTQ	CFHR4	61	Q92496
NFVTPSGSYWDYIHC	CFHR4	306	Q92496
LYHSSCVWSVEVYPE	MAPKBP1	386	O60336
PAVYTSVCHYLDWIQ	KLK9	231	Q9UKQ9
VQTPYAFYHWQCIDV	ENGASE	146	Q8NFI3
YTCVLGFHVYGVWPD	EML3	776	Q32P44
TSWEYPDVCRHYFGS	SLC38A9	181	Q8NBW4
YTFYHHCQAEGRPEW	NLGN2	481	Q8NFZ4
YTFCGWIVLGPYHDK	MCOLN2	431	Q8IZK6
ICWLPYHLYFILGSF	TACR2	261	P21452
PYIDYLHTGADCIWY	JARID2	936	Q92833
SFYPWHTGRDYQQLC	MIOX	221	Q9UGB7
AYCTHILSLYFPWDG	MTX1	381	Q13505
TAWIPFHGHCYYIES	MRC1	1236	P22897
PVSWISCGYYHSAFV	RPGR	191	Q92834
ENSGYYYCHVSLWAP	PTGFRN	366	Q9P2B2
CQYLFSWYTSAVCPL	IGF2R	2266	P11717
TCLVGYKGHNYPVWD	TAF5	576	Q15542
PVFTVSLWLYLLHYC	SEL1L3	286	Q68CR1
YITHIDDPWTFYCQL	TDRD6	991	O60522
SSACYNPFIYAWLHD	PRLHR	326	P49683
CDLPGASTLYIHWYL	TRGV1	41	A0A0A0MS02
IYGFSSFWYHCFRPS	TEDDM1	216	Q5T9Z0
YRCFYGSHTAGWSEP	LILRA1	96	O75019
LPLHGYLCQWTLVTY	RHOT2	356	Q8IXI1
GPNDSACVSWIYYSA	HEPH	871	Q9BQS7
LYQCWATENGFSYPV	SEMA4A	621	Q9H3S1
HQPWSQEAVSRYFYC	SMARCD3	451	Q6STE5
FSSWAQLYGITFSHP	ST6GALNAC6	316	Q969X2
PYVYGFSVSLICTLW	OR5M9	146	Q8NGP3
TNHIIIPSYASWFDY	SMARCC1	446	Q92922
IPSYASWFDYNCIHV	SMARCC1	451	Q92922
PKSLHQDYSEGYSWC	HES5	81	Q5TA89
GAWVQYTSIFCPEYS	CAMKMT	86	Q7Z624
RCSPISGHTSVYWYQ	TRBV5-8	41	A0A5A2
YFTVTLGIPAWCSYV	TMX4	176	Q9H1E5
EYSCHGVPTIEWTYS	VSTM5	56	A8MXK1
TVCDSSYWHNGPYNA	SLITRK1	666	Q96PX8
WTIPQGHFDSFTVQY	TNXB	2756	P22105
VNHEWYPHYFVLTSS	PLCG1	501	P19174
LLVSCPNYTYEVGSW	TECR	241	Q9NZ01
CADPAAHAPTLYTWY	SIGLEC1	1281	Q9BZZ2
DCTPEKGHTFVYWYQ	TRBV23-1	41	A0A0A0MS06
LGATLTYTYRHCWPH	TNFRSF25	216	Q93038
QYSIVDYCWLSPHNA	PLPP6	271	Q8IY26
PFYHIWNGTQRYLHC	UNC5A	676	Q6ZN44
LHCETTYTKDGFWTY	ZDHHC17	506	Q8IUH5
DQYCWQHRFPTGYFS	ZC3H7A	891	Q8IWR0
DWCYEATYSQLAHPI	TIMM44	341	O43615
RIFSNWGHPEYTCLY	SUN1	761	O94901
FLVSCPNYTYEIGSW	TECRL	296	Q5HYJ1
FWSNYPYEPVCLASH	WHAMMP3	6	Q1A5X7
AVYILCYLSFWDSPS	XKR5	246	Q6UX68
THASVYEAGPCWVLY	SLC30A1	301	Q9Y6M5
FLWYLIYGHPASNTV	GTF3C1	806	Q12789
YTNWSTSPYFLEHGI	TSPAN7	156	P41732
TPFETIYTGLWSYNC	SLC14A2	336	Q15849
FPSYYSPQTHCSWHL	TMPRSS6	356	Q8IU80
YHPVGERWYTENTCT	ZAN	1876	Q9Y493